Why Farbe Firma is the Leading Injectable Manufacturer in Sao Tome and Principe
Why Farbe Firma is the Leading Injectable Manufacturer in Sao Tome and Principe
Last Updated: 18 September 2026
TL;DR: Sao Tome and Principe has no national product registration procedure to file into. The Ministry of Health's own Politica Farmaceutica Nacional 2019-2029 states the non-existence of procedures for the approval and registration of medicines, so there is no marketing authorisation to win and no recognition list. The operative gates sit elsewhere: the licensed local importer, customs, and for donor-funded volume the Global Fund quality assurance policy, which India's CDSCO credentials do not satisfy for a non-vaccine injectable.
Key Takeaways
The framework statute, Lei n.o 09/2018 (Lei Base de Saude), commenced 30 days after publication on 6 June 2018. Article 1(l) defines an Autoridade de Medicamentos but does not establish one, and Article 24 defers pharmaceutical activity to separate legislation we could not find.
The absence of a product register is not an inference. The national pharmaceutical policy affirmatively records the non-existence of approval and registration procedures. That is a proven absence, unlike the many items below that we simply could not find.
There is no recognised or reference authority list, so asking whether India's CDSCO appears on it is a category error. You cannot be omitted from a list that does not exist.
For donor-funded volume the gate is the Global Fund quality assurance policy, not national law. Its stringent-authority test is closed to regulators that were ICH members or observers before 23 October 2015, and India's WHO transitional listed-authority entry is scoped to vaccines.
Introduction: What an Injectable Manufacturer in Sao Tome and Principe Actually Has to Clear
Most country guides for exporters open by explaining how to register a product. For Sao Tome and Principe that framing collapses at once, because the thing that would do the registering has not been built. The national pharmaceutical policy cites a population of 201,784 on a 2018 INE projection, a WHO AFRO profile gives roughly 219,160 for 2020, and later estimates run higher. We are not choosing between those figures, and neither should a supplier building a volume forecast.
The governing instrument is Lei n.o 09/2018, the Lei Base de Saude, published on 6 June 2018 and in force roughly a month later. It repealed the 1980 Codigo Sanitario, the only instrument that had contained detailed pharmaceutical machinery, and replaced it with a deferral: Article 24 states that pharmaceutical activity has its own specific legislation, and Article 50 obliges the Government to issue implementing instruments. Whether any medicines decree has since been enacted we could not establish. That is a not found, not proof either way.
What Sets a World-Class Injectable Manufacturer in Sao Tome and Principe Apart
What distinguishes a serious supplier is refusing to read an empty register as an open door. There is no marketing authorisation to obtain, which also means there is no regulatory asset to acquire: no certificate, no data exclusivity, nothing stopping the next supplier following you in a month later. The absence of a registration procedure removes your cost of entry and your moat at once, and it is not an affirmative legal permission to import.
The constraints that bite sit on the counterparty and the border. Pharmacy and establishment licensing runs through Decreto-Lei 53/78 and Article 47 of Lei 09/2018, which subjects private health units including pharmacies to State licensing. Customs duty is put at 5 to 10 per cent depending on product, with Ministry of Health imports excepted, and the ministry recommends making clearance faster, which implies it is not. What documents an importer must file at that border we could not establish, and we will not invent a checklist.
Quality Systems Behind Every Batch Shipped to Sao Tome and Principe
Farbe Firma manufactures sterile injectables under WHO-GMP certification with ISO Class 5 aseptic filling in Gujarat, India, supported by in-house HPLC, GC, LAL endotoxin and Karl Fischer testing and ICH Q1A and Q1B stability programmes. Every batch ships with a certificate of analysis traceable to retained samples, and we prepare CTD and ACTD dossiers as standard for the 30+ countries we export to. Here that documentation is not a filing requirement. It is the only independent quality evidence anyone in the chain will have.
That matters because the policy is candid about the country's own capacity. Quality control is not carried out systematically, samples travel to external laboratories because there is no national quality control laboratory, and inspection is limited to documentary and visual checks. Pharmacovigilance still requires legal cover. Distribution does not meet good storage and distribution practice, particularly for thermolabile medicines, which argues for room-temperature-stable presentations where the molecule allows.
Why Farbe Firma is the Trusted Injectable Manufacturer in Sao Tome and Principe for Global Buyers
The next question is whether a regional regime fills the national gap. It does not. Sao Tome and Principe is not an ECOWAS member, a point worth stating because it is often assumed. It is a founder of ECCAS, but we found no ECCAS medicines harmonisation instrument and no mutual recognition route; the literature describes ECCAS states as unharmonised. CPLP membership brings a cooperation aspiration in Article 12(3) of Lei 09/2018, not a pathway. The country appears on neither the signature nor the ratification list for the African Medicines Agency treaty, and the two are not the same.
So the volume worth winning tends to flow through donor channels, where the rules are not Sao Tomean at all. A Global Fund malaria grant reported at around US$6 million is channelled through UNDP, so UN procurement rules and the Global Fund quality assurance policy govern eligibility. That policy requires WHO prequalification, authorisation by a stringent regulatory authority or WHO Listed Authority, or a time-limited Expert Review Panel recommendation. On the agency routes an Indian file fails twice over, and we would rather say so than let a client discover it inside a tender.
The two reasons are independent and both easy to miss. The Global Fund's definition limits stringent authorities to those that were ICH members or observers before 23 October 2015, and CDSCO became a standing observer only in 2019. Separately, India's entry on WHO's published transitional listed-authority list carries the scope Vaccines, where Ghana, Nigeria and Tanzania are scoped Medicines. A non-vaccine injectable derives nothing from either. The honest conclusion is the inverse of the intuitive one: the investment that matters is WHO prequalification or an ERP pathway plus a licensed local importer, not a dossier with nowhere to go.
Explore Farbe Firma: Products / Global Reach / About Us
Frequently Asked Questions (FAQ)
Do I need to register my injectable before it can be sold there?
There is no procedure to register into. The Ministry of Health's national pharmaceutical policy states in terms that procedures for approval and registration of medicines do not exist, and lists establishing them among its forward directives. This is one of the very few things here that is a proven absence rather than something we merely could not find. Read it carefully though: no register is not the same as permission to import, because the importer licence, customs and any ad hoc ministerial authorisation remain live and undocumented gates.
Is India's CDSCO on a recognised or reference authority list?
The question is a category error and we will answer it as one rather than give a tidy yes or no. There is no list of recognised or stringent authorities, because there is no registration procedure for reliance or abridgement to attach to. CDSCO is not on such a list, and equally has not been excluded from one, because exclusion presupposes a list. A named list does bite at the donor layer.
What are the registration fees and review timelines?
We found none, from any source, in either direction, consistent with there being no registration procedure to charge for. We will not publish a number we cannot support, and you should treat any guide quoting one with suspicion. The only monetary figures we located are a customs duty of 5 to 10 per cent depending on product, with Ministry of Health imports excepted, and fines in the repealed 1980 code. Neither is a registration fee.
Who actually buys, and can I appoint a national distributor?
The public sector is supplied through the Fundo Nacional de Medicamentos, created by Decreto-Lei 52/98, with a planned transformation into CAME. Whether that has happened we cannot say: the primary policy frames CAME as planned while a secondary page describes it in the present tense, and sources even differ on what the acronym expands to. We are not choosing. On the private side the policy records that pharmacies import for themselves because the country lacks a wholesale distributor company, so your counterparty is likely a single pharmacy or small importer, not a national distributor.
In what language should labels and product information be supplied?
Portuguese, for labelling and patient information. The policy requires INN presentation on packaging, labels, inserts and promotional material in Portuguese, and complains that dispensed products currently arrive without a Portuguese-language patient leaflet. What we will not tell you is that dossiers must be submitted in Portuguese, because we found no dossier procedure for a language rule to attach to. Two further cautions from the same document: the informal market is described as predominant, and donations other than one named project arrive without criteria safeguarding quality.
Technically Reviewed By: Maulik Sudani (Technical Expert) | Jignasu Sudani (Technical Expert), Farbe Firma Pvt Ltd, Gujarat, India.
Farbe Firma Pvt Ltd - WHO-GMP certified sterile injectable manufacturer and CDMO, Gujarat, India. ISO Class 5 aseptic filling, CTD/ACTD dossiers, exporting to 30+ countries. director@farbefirma.orgRequest a Quote / View Products / Blog
Comments